Michael S Anderson - Net Worth and Insider Trading

Michael S Anderson Net Worth

The estimated net worth of Michael S Anderson is at least $4 Million dollars as of 2024-05-17. Michael S Anderson is the CEO of Avadel Pharmaceuticals PLC and owns about 248,953 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $4 Million. Details can be seen in Michael S Anderson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael S Anderson has not made any transactions after 2018-08-10 and currently still holds the listed stock(s).

Transaction Summary of Michael S Anderson

To

Michael S Anderson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael S Anderson owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and Healthcare Trust Inc (HTIA.PFD) .

Click here to see the complete history of Michael S Anderson’s form 4 insider trades.

Insider Ownership Summary of Michael S Anderson

Ticker Comapny Transaction Date Type of Owner
AVDL Avadel Pharmaceuticals PLC 2018-08-10 director & Chief Executive Officer
HTIA.PFD Healthcare Trust Inc 2023-09-12 Chief Executive Officer

Michael S Anderson Latest Holdings Summary

Michael S Anderson currently owns a total of 1 stock. Michael S Anderson owns 248,953 shares of Avadel Pharmaceuticals PLC (AVDL) as of August 10, 2018, with a value of $4 Million.

Latest Holdings of Michael S Anderson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AVDL Avadel Pharmaceuticals PLC 2018-08-10 248,953 15.49 3,856,282

Holding Weightings of Michael S Anderson


Michael S Anderson Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael S Anderson has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 16,297 shares on August 10, 2018, which brought Michael S Anderson around $80,018.

Insider Trading History of Michael S Anderson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael S Anderson Trading Performance

GuruFocus tracks the stock performance after each of Michael S Anderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S Anderson is -10.46%. GuruFocus also compares Michael S Anderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S Anderson within 3 months outperforms 1 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael S Anderson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael S Anderson

Average Return

Average return per transaction

Outperforming Transactions

2 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.12
Relative Return to S&P 500(%) 0.98

Michael S Anderson Ownership Network

Ownership Network List of Michael S Anderson

No Data

Ownership Network Relation of Michael S Anderson


Michael S Anderson Owned Company Details

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Michael S Anderson is the director & Chief Executive Officer of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Michael S Anderson made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

Michael S Anderson Mailing Address

Above is the net worth, insider trading, and ownership report for Michael S Anderson. You might contact Michael S Anderson via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.

Discussions on Michael S Anderson

No discussions yet.